Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Antony Blinken cancels China trip following discovery of spy balloon
    • US accuses China of flying spy balloon over sensitive military sites
    • US jobs total surges by over half a million in January
    • Madison Square Garden owner battles outcry over ‘dystopian’ blacklisting
    • Nigeria’s attempt to replace its currency notes descends into chaos
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • TotalEnergies says exposure to Adani stands at $3.1bn as turmoil mounts
      • Billionaire Disney insider becomes pivotal figure in Nelson Peltz’s proxy fight
      • EY considers handing retired US partners cut of proceeds from spin-off
      • BT chief warns Openreach fibre push will ‘end in tears’ for rivals
      • Carlyle courts ex-Goldman executive Harvey Schwartz for CEO
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Live news updates from February 3: US jobs gains surge unexpectedly, FTSE 100 hits record high
      • UK’s FTSE 100 share index beats 2018 peak to hit all-time high
      • The battle for the Colorado River is a water warning to us all
      • Nigeria’s attempt to replace its currency notes descends into chaos
      • Nasdaq closes 3.3% higher as investors bet rates are close to peak levels
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
      Most Read
      • The return of the ‘British disease’
      • Britain should not accept its status as the ‘sick man of Europe’
      • OK boomer, you’re more generous than we thought
      • How to fix the British economy
      • What chimpanzees tell us about how humans see data
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • A new generation refuses to keep quiet on age discrimination at work
      • Shoshana Zuboff: ‘Privacy has been extinguished. It is now a zombie’
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Germany grapples with the limits of pacifism
      • After hours with 10 Foot, London’s most notorious graffiti writer
      • Rugby superstar Siya Kolisi: ‘I’ve got no ego at all’
      • Retiring at 62? The French have it absolutely right
      • Bill Gates is probed and baited in BBC interview with Amol Rajan — TV review
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Anjana Ahuja

    Science Commentator

    Anjana Ahuja is a contributing writer on science, offering weekly opinion on significant developments in global science, health and technology. She was previously a feature writer and columnist at The Times in London.

    She is the co-author, with Professor Mark Van Vugt, of Selected: Why Some People Lead, Why Others Follow, and Why It Matters (2010), on the evolution of human leadership. With Sir Jeremy Farrar, she also co-authored the bestselling Spike: The Virus Vs The People (2021/updated paperback 2022), on the inside story of the Covid-19 pandemic. Spike was shortlisted for the 2022 Orwell Prize for Political Writing and is shortlisted for the 2022 Royal Society Science Book Prize.

    Anjana has a PhD in space physics from Imperial College London, and studied journalism at City University, London.

    Email Anjana Ahuja @anjahuja  on Twitter (link opens in a new browser window)

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Tuesday, 31 January, 2023
      Genomics
      Dead as a dodo? The unsettling bid to bring back extinct species

      We should focus on conserving endangered animals rather than resurrecting those already gone

    • Tuesday, 24 January, 2023
      Climate change
      ExxonMobil shows the perils of corporate science

      The conglomerate’s research on climate change was much more accurate than its public messaging

    • Tuesday, 24 January, 2023
      Environment6 min
      Battling the avian flu epidemic | FT Food Revolution

      The FT's Anjana Ahuja reports on how virologists are unlocking the secrets of the latest H5N1 avian flu strain

    • Wednesday, 18 January, 2023
      Innovation
      Science is losing its ability to disrupt

      The decline in truly revolutionary research may have serious implications for humanity

    • Wednesday, 11 January, 2023
      Dementia
      New Alzheimer’s drug straddles uneasy gulf between help and harm

      For all its landmark status, lecanemab may end up representing a triumph of hope over evidence

    • Thursday, 5 January, 2023
      ReviewFT Books Essay
      Can awe change the way we see the world?

      Two books encourage us to look at life afresh — via the senses and cultivating a sense of wonder in our day-to-day lives

    • Wednesday, 4 January, 2023
      Coronavirus pandemic
      We may be entering Covid’s least predictable year yet

      China’s unleashing of the virus is raising questions about the potential for harmful, new variants

    • Wednesday, 21 December, 2022
      Artificial intelligence
      ‘Grief tech’ avatars aim to take the sting out of death

      Personalised chatbots hope to console the bereaved but the ethics remain complicated

    • Wednesday, 14 December, 2022
      Hydrogen power
      Seawater electrolysis ignites new hope for affordable green hydrogen

      Researchers in China claim their technique bypasses the need for desalination

    • Tuesday, 6 December, 2022
      Agricultural production
      Why lab-grown meat may never be on the menu

      High production costs together with increasingly vegetarian appetites may prevent this industry taking off

    • Tuesday, 29 November, 2022
      Artificial intelligence
      A Machiavellian machine raises ethical questions about AI

      Researchers have developed a bot capable of the deceptions required to prosper in an online diplomacy game

    • Thursday, 24 November, 2022
      FT SeriesBest books of the year 2022
      Best books of 2022: Health and wellbeing

      Anjana Ahuja selects her must-read titles

    • Wednesday, 23 November, 2022
      Health
      ‘Immunity debt’ is a misguided and dangerous concept

      There is no evidence that an individual is worse off for having avoided earlier infection

    • Tuesday, 8 November, 2022
      Utilities
      Lazy winds could blow Europe’s renewable future off course

      We need to future-proof against the phenomenon of ‘global stilling’

    • Tuesday, 25 October, 2022
      Satellites
      We are dangerously reliant on GPS to tell the time

      Recent outages in satellite systems have confirmed the importance of data from atomic clocks as an invisible utility

    • Tuesday, 18 October, 2022
      Science
      Making research funding a lottery could help tackle ‘status bias’

      The system of peer review tends to favour established names and institutions

    • Tuesday, 11 October, 2022
      Science
      What quantum physics tells us about reality

      The new Nobel laureates proved Einstein was not always right

    • Tuesday, 27 September, 2022
      Science
      Deflecting asteroids is only one thing on humanity’s worry list

      Nasa’s mission gives hope we can defend our planet but human nature and technology present risks of their own

    • Tuesday, 20 September, 2022
      Climate change
      ‘Magic numbers’ are clouding the climate debate

      Better metrics would allow scientists to link abstract data with everyday experience

    • Wednesday, 14 September, 2022
      Science
      What grief does to those left behind

      Losing a spouse has a physical impact as well as a psychological one

    • Tuesday, 6 September, 2022
      Medical science
      The energy crisis puts a health time-bomb under Britain’s most vulnerable

      Without immediate political intervention, spiralling costs will widen inequality and shorten lives

    • Tuesday, 23 August, 2022
      ReviewScience books
      Nomad Century by Gaia Vince — acclimatising to crisis

      This hard-hitting must-read sets out where will be habitable in a hothouse world and how we should manage the transition

    • Wednesday, 17 August, 2022
      Medical science
      The spread of bird flu demands a sharper response

      Tightening biosecurity and widening surveillance is a sensible strategy to protect both animals and people

    • Tuesday, 9 August, 2022
      UK social mobility
      Rich and poor should mingle more

      New research suggests that children from low-income families who are friends with wealthier peers will earn more later in life

    • Tuesday, 26 July, 2022
      Medical science
      To combat disease, science must look beyond the Kardashian of proteins

      P53 is the most studied protein in the human body, but researchers are expanding their horizons

    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition
    • Top sections
    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports
    • FT recommends
    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • FTfm
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In